keyword
https://read.qxmd.com/read/37866803/adiporon-and-adp355-adiponectin-receptor-agonists-in-metabolic-associated-fatty-liver-disease-mafld-and-nonalcoholic-steatohepatitis-nash-a-systematic-review
#21
REVIEW
Sandra Maria Barbalho, Nahum Méndez-Sánchez, Lucas Fornari Laurindo
Adiponectin replacement therapy holds the potential to benefit numerous human diseases, and ongoing research applies particular interest in how adiponectin acts against Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH). However, the pharmacological limitations of the intact protein have prompted a focus on alternative options, specifically peptidic and small molecule agonists targeting the adiponectin receptor. AdipoRon is an extensively researched non-peptidic drug candidate in adiponectin replacement therapy...
October 20, 2023: Biochemical Pharmacology
https://read.qxmd.com/read/37865846/assessing-the-efficacy-of-duration-and-intensity-prescription-for-physical-activity-in-mitigating-cardiometabolic-risk-after-spinal-cord-injury
#22
JOURNAL ARTICLE
Gary J Farkas, Lizeth J Caldera, Mark S Nash
PURPOSE OF REVIEW: Spinal cord injury (SCI) heightens susceptibility to cardiometabolic risk (CMR), predisposing individuals to cardiovascular disease. This monograph aims to assess the optimal duration and intensity of physical activity (PA) for managing CMR factors, particularly obesity, after SCI and provide modality-specific PA durations for optimal energy expenditure. RECENT FINDINGS: PA guidelines recommend at least 150 min/week of moderate-intensity activity...
September 27, 2023: Current Opinion in Neurology
https://read.qxmd.com/read/37823453/relevance-of-glp-1-receptor-agonists-or-sglt-2-inhibitors-on-the-recruitment-for-clinical-studies-in-patients-with-nafld
#23
JOURNAL ARTICLE
Michael Holzhey, David Petroff, Kerstin Wirkner, Christoph Engel, Ronny Baber, Anke Tönjes, Samira Zeynalova, Maryam Yahiaoui-Doktor, Thomas Berg, Thomas Karlas, Johannes Wiegand
INTRODUCTION: Guidelines increasingly recommend the use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose co-transporter-2 inhibitors (SGLT2i) to prevent cardiovascular and cardiorenal endpoints. Both drugs also show beneficial effects in nonalcoholic fatty liver disease (NAFLD). Preexisting GLP-1 RA and SGLT2i therapies are frequently defined as exclusion criterion in clinical studies to avoid confounding effects. We therefore investigated how this might limit recruitment and design of NAFLD studies...
October 6, 2023: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/37816527/clinical-practice-guideline-for-management-of-osteoporosis-and-fracture-prevention-in-canada-2023-update
#24
JOURNAL ARTICLE
Suzanne N Morin, Sidney Feldman, Larry Funnell, Lora Giangregorio, Sandra Kim, Heather McDonald-Blumer, Nancy Santesso, Rowena Ridout, Wendy Ward, Maureen C Ashe, Zahra Bardai, Joan Bartley, Neil Binkley, Steven Burrell, Debra Butt, Suzanne M Cadarette, Angela M Cheung, Phil Chilibeck, Sheila Dunn, Jamie Falk, Heather Frame, William Gittings, Kaleen Hayes, Carol Holmes, George Ioannidis, Susan B Jaglal, Robert Josse, Aliya A Khan, Virginia McIntyre, Lynn Nash, Ahmed Negm, Alexandra Papaioannou, Matteo Ponzano, Isabel B Rodrigues, Lehana Thabane, Christine A Thomas, Lianne Tile, John D Wark
BACKGROUND: In Canada, more than 2 million people live with osteoporosis, a disease that increases the risk for fractures, which result in excess mortality and morbidity, decreased quality of life and loss of autonomy. This guideline update is intended to assist Canadian health care professionals in the delivery of care to optimize skeletal health and prevent fractures in postmenopausal females and in males aged 50 years and older. METHODS: This guideline is an update of the 2010 Osteoporosis Canada clinical practice guideline on the diagnosis and management of osteoporosis in Canada...
October 10, 2023: Canadian Medical Association Journal: CMAJ
https://read.qxmd.com/read/37769817/nonalcoholic-fatty-liver-disease-current-therapies-and-future-perspectives-in-drug-delivery
#25
JOURNAL ARTICLE
Inês Domingues, Isabelle A Leclercq, Ana Beloqui
Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the adult population worldwide. This pathology can progress into end-stage liver disease with life-threatening complications, and yet no pharmacologic therapy has been approved. NAFLD is commonly characterized by excessive fat accumulation in the liver and is in closely associated with insulin resistance and metabolic disorders, which suggests that NAFLD is the hepatic manifestation of metabolic syndrome. Regarding treatment options, the current validated strategy relies on lifestyle modifications (exercise and diet restrictions)...
October 1, 2023: Journal of Controlled Release
https://read.qxmd.com/read/37768417/screening-diagnosis-and-staging-of-non-alcoholic-fatty-liver-disease-nafld-application-of-society-guidelines-to-clinical-practice
#26
REVIEW
Ysabel C Ilagan-Ying, Bubu A Banini, Albert Do, Robert Lam, Joseph K Lim
PURPOSE OF REVIEW: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly nonalcoholic fatty liver disease (NAFLD), is the most common chronic liver disease affecting 30% of the global population. In this article, we summarize current expert guidelines, review clinical practice implications, and provide insight into the utility of non-invasive tests (NITs). RECENT FINDINGS: The burden of MASLD is growing with the obesity epidemic, yet disease awareness and diagnosis is low...
October 2023: Current Gastroenterology Reports
https://read.qxmd.com/read/37730302/guideline-no-442-fetal-growth-restriction-screening-diagnosis-and-management-in-singleton-pregnancies
#27
JOURNAL ARTICLE
John Kingdom, Eran Ashwal, Andrea Lausman, Jessica Liauw, Nancy Soliman, Ernesto Figueiro-Filho, Christopher Nash, Emmanuel Bujold, Nir Melamed
OBJECTIVE: Fetal growth restriction is a common obstetrical complication that affects up to 10% of pregnancies in the general population and is most commonly due to underlying placental diseases. The purpose of this guideline is to provide summary statements and recommendations to support a clinical framework for effective screening, diagnosis, and management of pregnancies that are either at risk of or affected by fetal growth restriction. TARGET POPULATION: All pregnant patients with a singleton pregnancy...
October 2023: Journal of Obstetrics and Gynaecology Canada: JOGC
https://read.qxmd.com/read/37723060/-liver-fibrosis-screening-evaluation-pathway-and-management-in-patients-with-fatty-liver
#28
JOURNAL ARTICLE
L Xu, Y Q Mi
Non-alcoholic fatty liver disease (NAFLD) is not a benign condition, especially in patients with non-alcoholic steatohepatitis (NASH) combined with liver fibrosis grades F2-4, who have a higher risk of liver-related events and mortality. Thus, this population is considered "at-risk" for developing NASH. China has a large NAFLD patient population, so how to screen for those with liver fibrosis is an important socio-economic concern. At the moment, serological models, liver stiffness detection based on vibration-controlled transient elastography, and magnetic resonance elastography (MRE) are the only non-invasive tests (NITs) for liver fibrosis...
August 20, 2023: Zhonghua Gan Zang Bing za Zhi, Zhonghua Ganzangbing Zazhi, Chinese Journal of Hepatology
https://read.qxmd.com/read/37719477/vitamin-e-and-pioglitazone-a-comprehensive-systematic-review-of-their-efficacy-in-non-alcoholic-fatty-liver-disease
#29
REVIEW
Iqra J Mazhar, Mohamed Yasir, Saba Sarfraz, Gandhala Shlaghya, Sri Harsha Narayana, Ujala Mushtaq, Basim Shaman Ameen, Chuhao Nie, Daniel Nechi, Sai Sri Penumetcha
Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent worldwide, especially in people with obesity, dyslipidemia, type 2 diabetes mellitus (T2DM), and metabolic syndrome. Weight loss and dietary modifications are established first-line treatments for NAFLD. Currently, there is no approved drug for NAFLD; however, pioglitazone and vitamin E have shown some beneficial effects. This systematic review covers the comparative efficacies of vitamin E, pioglitazone, and vitamin E plus pioglitazone...
August 2023: Curēus
https://read.qxmd.com/read/37664266/non-alcoholic-steatohepatitis-in-asians-current-perspectives-and-future-directions
#30
REVIEW
Gourdas Choudhuri, Saumin Shah, Anand Kulkarni, Nitin Jagtap, Pratyusha Gaonkar, Akshay Desai, Charles Adhav
Non-alcoholic steatohepatitis (NASH) is a subset of non-alcoholic fatty liver disease (NAFLD), which, apart from excess fat in the liver, may be characterised by some level of inflammatory infiltration and fibrogenesis, occasionally progressing to liver cirrhosis or hepatocellular carcinoma (HCC). The objective of the current review is to elucidate the rising prevalence, the role of microbiome and genetics in pathogenesis, diagnostic challenges, and novel treatment alternatives for NASH. Newer diagnostic techniques are being developed since using liver biopsy in a larger population is not a reasonable option and is primarily restricted to clinical research, at least in developing countries...
August 2023: Curēus
https://read.qxmd.com/read/37661826/features-of-fatal-pesticide-ingestion-in-south-australia
#31
JOURNAL ARTICLE
Lilli Stephenson, Corinna Van Den Heuvel, Melissa Humphries, Christine Nash, Roger W Byard
Pesticides are used to kill, repel or control any animal or plant species which are considered pests, but have also been associated with intentional and unintentional human fatalities. A rapid increase in pesticide suicides was observed during 'The Green Revolution' after pesticides were introduced into low- and middle-income rural households without appropriate guidelines for safe use and storage. While national pesticide bans have contributed to a significant decrease in pesticide-related suicides, such cases still comprise a large proportion of all suicides around the world...
September 4, 2023: Medicine, Science, and the Law
https://read.qxmd.com/read/37655589/major-incident-hospital-simulations-in-hospital-based-health-care-a-scoping-review
#32
REVIEW
Sacha Wynter, Rosie Nash, Nicola Gadd
Major incidents are occurring in increasing frequency, and place significant stress on existing health-care systems. Simulation is often used to evaluate and improve the capacity of health systems to respond to these incidents, although this is difficult to evaluate. A scoping review was performed, searching 2 databases (PubMed, CINAHL) following PRISMA guidelines. The eligibility criteria included studies addressing whole hospital simulation, published in English after 2000, and interventional or observational research...
September 1, 2023: Disaster Medicine and Public Health Preparedness
https://read.qxmd.com/read/37646879/diagnosing-provider-referral-patterns-facility-type-and-patient-satisfaction-among-iowa-rectal-cancer-patients
#33
JOURNAL ARTICLE
Sarah Nash, Kristin Weeks, Amanda R Kahl, Natalie J Del Vecchio, Xiang Gao, Kristina Guyton, Mary Charlton
PURPOSE: Rectal cancer treatment at high-volume centers is associated with higher likelihood of guideline-concordant care and improved outcomes. Whether rectal cancer patients are referred for treatment at high-volume hospitals may depend on diagnosing provider specialty. We aimed to determine associations of diagnosing provider specialty with treating provider specialty and characteristics of the treating facility for rectal cancer patients in Iowa. METHODS: Rectal cancer patients identified using the Iowa Cancer Registry completed a mailed survey on their treatment experience and decision-making process...
August 30, 2023: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/37606503/flow-cytometry-method-validation-protocols
#34
JOURNAL ARTICLE
Nithianandan Selliah, Veronica Nash, Steven Eck, Cherie Green, Teri Oldaker, Jennifer Stewart, Alessandra Vitaliti, Virginia Litwin
Analytical method validation provides a means to ensure that data are credible and reproducible. This article will provide a brief introduction to analytical method validation as applied to cellular analysis by flow cytometry, along with practical procedures for four different types of validation. The first, Basic Protocol 1 (the limited validation protocol), is recommended for research and non-regulated laboratories. Next, Basic Protocol 2) presents a reasonable, fit-for-purpose validation approach appropriate for biopharma and research settings...
August 2023: Current protocols
https://read.qxmd.com/read/37563849/a-global-survey-of-health-care-workers-awareness-of-non-alcoholic-fatty-liver-disease-the-awarenash-survey
#35
JOURNAL ARTICLE
Stan Driessen, Vivian D de Jong, Koen C van Son, Tatiana Klompenhouwer, Yann Colardelle, Marco Alings, Cristophe Moreno, Stefan D Anker, Manuel Castro Cabezas, Adriaan G Holleboom, Diederick E Grobbee, Maarten E Tushuizen
BACKGROUND: The estimated global prevalence and burden of non-alcoholic fatty liver disease (NAFLD) and its advanced stage, non-alcoholic steatohepatitis (NASH), is increasing. Yet, NAFLD remains largely underdiagnosed. In addition to hepatic morbidity and mortality, NAFLD is associated with increased cardiovascular complications, warranting a multidisciplinary approach. Despite its rapidly increasing prevalence, knowledge of NAFLD among healthcare workers is limited, especially with specialists outside the field of hepatology and gastroenterology...
August 10, 2023: United European Gastroenterology Journal
https://read.qxmd.com/read/37527759/liver-biopsy-based-validation-confirmation-and-comparison-of-the-diagnostic-performance-of-established-and-novel-non-invasive-non-alcoholic-fatty-liver-disease-indexes-results-from-a-large-multi-center-study
#36
JOURNAL ARTICLE
Matina Kouvari, Laura Valenzuela-Vallejo, Valentina Guatibonza-Garcia, Stergios A Polyzos, Yixiang Deng, Michail Kokkorakis, Melih Agraz, Sophia C Mylonakis, Angeliki Katsarou, Ornella Verrastro, Georgios Markakis, Mohammed Eslam, Georgios Papatheodoridis, Jacob George, Geltrude Mingrone, Christos S Mantzoros
BACKGROUND: Non-invasive tools (NIT) for non-alcoholic fatty liver disease (NAFLD) screening or diagnosis need to be thoroughly validated using liver biopsies. PURPOSE: To externally validate NITs designed to differentiate the presence or absence of liver steatosis as well as more advanced disease stages, to confirm fully validated indexes (n = 7 NITs), to fully validate partially validated indexes (n = 5 NITs), and to validate for the first time one new index (n = 1 NIT)...
July 30, 2023: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/37501636/australian-consensus-treatment-goals-for-moderate-to-severe-psoriasis-in-the-era-of-targeted-therapies-adult-patients
#37
JOURNAL ARTICLE
Peter Foley, Kurt Gebauer, John Sullivan, Erin McMeniman, Stephen Shumack, Jonathan Ng, Amelia James, Morton Rawlin, Shireen Sidhu, Dev Tilakaratne, Murray Turner, Barbara Radulski, Peter Nash, Christopher Baker
BACKGROUND: Over the last decade, the treatment landscape for moderate-severe psoriasis has rapidly evolved. The Australasian College of Dermatologists sought to review and update previously published treatment goals for moderate-severe psoriasis. METHODS: A modified Delphi approach was used. Comprehensive literature review and guideline evaluation resulted in the development of statements and other questions to establish current clinical practices. Two rounds of anonymous voting were undertaken, with a collaborative meeting held in between to discuss areas of discordance...
July 28, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/37459417/diagnosis-and-management-of-cardiovascular-risk-in-individuals-with-spinal-cord-injury-a-narrative-review
#38
REVIEW
Tara Lagu, Samantha L Schroth, Carol Haywood, Allen Heinemann, Allison Kessler, Leslie Morse, Sadiya S Khan, Kiarri N Kershaw, Mark S Nash
More than 16 000 Americans experience spinal cord injury (SCI), resulting in chronic disability and other secondary sequelae, each year. Improvements in acute medical management have increased life expectancy. Cardiovascular disease is a leading cause of death in this population, and seems to occur earlier in individuals with SCI compared with the general population. People with SCI experience a high burden of traditional cardiovascular disease risk factors, including dyslipidemia and diabetes, and demonstrate anatomic, metabolic, and physiologic changes alongside stark reductions in physical activity after injury...
July 18, 2023: Circulation
https://read.qxmd.com/read/37444147/the-association-of-moral-injury-and-healthcare-clinicians-wellbeing-a-systematic-review
#39
REVIEW
Pari Shah Thibodeau, Aela Nash, Jennifer C Greenfield, Jennifer L Bellamy
Research focused on elucidating moral injury amongst healthcare workers (HCWs) is essential due to the deep connection with morality and individuals' overall wellbeing. Examining moral injury provides an avenue through which researchers can connect individual experiences with systemic level causes (i.e., structural power imbalances between clinicians and health systems) to better study workplace wellbeing. The omnipresence of the COVID-19 pandemic has amplified the need to study moral injury. This paper describes a systematic review conducted using PRISMA-P guidelines to answer the question, "what is the association between moral injury and professional wellbeing and mental health amongst healthcare workers...
July 5, 2023: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/37436422/patterns-of-evidence-based-care-for-the-diagnosis-staging-and-first-line-treatment-of-breast-cancer-by-race-ethnicity-a-seer-medicare-study
#40
JOURNAL ARTICLE
Emma L Herbach, Sarah H Nash, Ingrid M Lizarraga, Ryan M Carnahan, Kai Wang, Amy C Ogilvie, Michaela Curran, Mary E Charlton
BACKGROUND: Racial and ethnic disparities in guideline-recommended breast cancer treatment are well documented, however studies including diagnostic and staging procedures necessary to determine treatment indications are lacking. The purpose of this study was to characterize patterns in delivery of evidence-based services for the diagnosis, clinical workup, and first-line treatment of breast cancer by race-ethnicity. METHODS: SEER-Medicare data were used to identify women diagnosed with invasive breast cancer between 2000 and 2017 at age 66 or older (n = 215,605)...
July 12, 2023: Cancer Epidemiology, Biomarkers & Prevention
keyword
keyword
91906
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.